Cepheid

Cepheid and Oxford Nanopore Technologies Partner to Advance Automated Sequencing-Based Solutions Read the full press release: https://ow.ly/jMJp50VxnGb

We are proud to announce that Cepheid achieved IVDR certification and is on track to convert its test portfolio. #Innovation #NearPatientTesting #Healthcare #IVDR #Cepheid #GenexpertSystem Stay tuned and discover more on our IVDR webpage: https://ow.ly/sPy950Vv14R

🔬 Elevate Your Approach to Antimicrobial Stewardship with Cepheid 🌏 Exciting news! Our Insight Hub now features an exclusive Antimicrobial Stewardship page — a go-to resource for the global in vitro diagnostics community. 💊 Dive into thought leadership articles, clinical evidence, research advancements, and impactful stories from across the globe. Learn how our cutting-edge diagnostic technologies are revolutionizing patient outcomes, enhancing resource allocation, and shaping the future of healthcare. #AntimicrobialResistance #Superbug #AntimicrobialStewardship Read more: https://lnkd.in/gawwsnUy

World Health Day 2025 recognizes maternal and newborn health. The campaign urges the health community to prioritize women’s health.* Cepheid supports the well-being and health of women around the globe. #WordHealthDay *https://lnkd.in/d8nVsj82

When it comes to sexual health, a diagnosis isn’t always crystal clear. In fact, co-infections can play a significant role in vaginitis symptoms, complicating diagnosis and treatment. Identifying and addressing co-infections is crucial for effective care and symptom relief. Cepheid’s Xpert® Xpress MVP simplifies testing for common causes of vaginitis and co-infections, all in one comprehensive test. Let’s empower patients with clarity and confidence. Learn more about Xpert Xpress MVP. #STIAwarness #WomensHealth US-IVD. In Vitro Diagnostic Medical Device. Learn More: https://ow.ly/FFof50VuQqj

For the first time, Cepheid and Beckman Coulter Diagnostics are attending ESCMID Global together! Find us at the Danaher booth #E10, where we are united behind the shared goal of solving complex health challenges for patients around the world, enabling healthcare providers to diagnose diseases with unprecedented speed and precision. Check out our in-booth presentation schedule and get the sessions on your calendar: https://ow.ly/A77S50VfV9G #ESCMID #InfectiousDisease

ECDC CPE Update Alert! The latest ECDC update calls for action against antimicrobial resistance: ✅ Develop a CRE management plan ✅ Implement enhanced IPC measures ✅ Apply antimicrobial stewardship ✅ Strengthen genomic surveillance ✅ Provide adequate lab capacity Due to high spread risk, ECDC urges surveillance of asymptomatic CPE carriers in the EU. Differentiating carbapenemase families is necessary for surveillance and treatment.(1) Xpert® Carba-R aligns with ECDC recommendations, offering rapid detection and differentiation of NDM, VIM, IMP, KPC, OXA-48 in just 50 minutes. #AMR #ECDC #CPE Stay informed and let’s take action together. Click here to download this update now: https://ow.ly/QmMN50VtmYa (1) European Centre for Disease Prevention and Control. Carbapenem-resistant Enterobacterales, third update – 3 February 2025. ECDC: Stockholm; 2025.

💡 Cristina Baker, Cepheid’s Senior Director of Medical and Scientific Affairs, discusses how scientific innovation can help bring us closer to an end to tuberculosis #EndTB   📲 Read her Expert Perspective on Cepheid’s Insight Hub: https://lnkd.in/gkjDfgTN

⚔ Fighting TB is everything: How South Africa has landed a significant blow on its tuberculosis burden.    🌏 Few things in global health are as worth investing in as childhood vaccination programs. Data from a new study suggest molecular diagnostics for tuberculosis (TB) might be one of them.     🔎 Read the impact evidence on Cepheid’s Insight Hub: https://ow.ly/Lwm450VqQ0H    #EndTB BMJ

For nearly three decades, we’ve strived to improve healthcare by developing diagnostic solutions that are fast, accurate, and flexible. #MolecularDiagnostics #BestTeamWins Learn more about our mission here: https://ow.ly/Tc0950VcZM4